<DOC>
	<DOCNO>NCT00782405</DOCNO>
	<brief_summary>The purpose study examine effect ( ) quetiapine XR ( b ) mirtazapine sleep give antidepressant ( monotherapy ) . We hypothesize ( ) quetiapine XR immediate last positive effect sleep depress patient differ impact mirtazapine sleep group patient ; ( b ) context secondary objective , expect antidepressant effect quetiapine XR equivalent mirtazapine .</brief_summary>
	<brief_title>Effect Quetiapine XR Sleep Patients With Major Depression , Compared With Mirtazapine</brief_title>
	<detailed_description />
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Mirtazapine</mesh_term>
	<mesh_term>Mianserin</mesh_term>
	<mesh_term>Quetiapine Fumarate</mesh_term>
	<criteria>1 . Provision write informed consent 2 . A diagnosis Major depressive disorder Diagnostic Statistical Manual Mental Disorders , Fourth Edition , revise ( DSMIVR ) 3 . Clinically significant sleep disturbance ( PSQI total score &gt; 5 ) 4 . Females male age 18 65 year 5 . Female patient childbearing potential must use reliable method contraception negative urine human chorionic gonadotropin ( HCG ) test enrolment 6 . Able understand comply requirement study 7 . Minimum score HAMD21 scale : 18 1 . Pregnancy lactation 2 . Any DSMIVR Axis I disorder define inclusion criterion 3 . Patients , opinion investigator , pose imminent risk suicide danger self others 4 . Known intolerance lack response quetiapine fumarate / mirtazapine , judge investigator 5 . Use follow cytochrome P450 3A4 inhibitor 14 day precede enrolment include limited : ketoconazole , itraconazole , fluconazole , erythromycin , clarithromycin , troleandomycin , indinavir , nelfinavir , ritonavir , fluvoxamine saquinavir 6 . Use follow cytochrome P450 3A4 inducer 14 day precede enrolment include limited : phenytoin , carbamazepine , barbiturate , rifampicin , St. John 's Wort , glucocorticoids 7 . Administration depot antipsychotic injection within one dose interval ( depot ) randomisation 8 . Substance alcohol dependence enrolment ( except dependence full remission , except caffeine nicotine dependence ) , define DSMIVR criterion 9 . Opiates , amphetamine , barbiturate , cocaine , cannabis , hallucinogen abuse DSMIVR criterion within 4 week prior enrolment 10 . Medical condition would affect absorption , distribution , metabolism , excretion study treatment 11 . Unstable inadequately treat medical illness ( e.g . congestive heart failure , angina pectoris , hypertension ) judge investigator 12 . Involvement plan conduct study 13 . Previous enrolment randomisation treatment present study . 14 . Participation another drug trial within 4 week prior enrolment study long accordance local requirement 15 . A patient Diabetes Mellitus ( DM ) fulfil one follow criterion : Unstable DM define enrolment glycosylated hemoglobin ( HbA1c ) &gt; 8.5 % . Admitted hospital treatment DM DM relate illness past 12 week . Not physician care DM Physician responsible patient 's DM care indicate patient 's DM control . Physician responsible patient 's DM care approve patient 's participation study Has dose oral hypoglycaemic drug ( ) and/or diet 4 week prior randomisation . For thiazolidinediones ( glitazones ) period le 8 Weeks . Taking insulin whose daily dose one occasion past 4 week 10 % mean dose precede 4 week Note : If diabetic patient meet one criterion , patient exclude even treat physician believe patient stable participate study . 16 . An absolute neutrophil count ( ANC ) â‰¤ 1.5 x 109 per liter 17 . Respiratory distress index 1st polysomnography &gt; 10 18 . Periodic leg movement / arousal index 1st polysomnography &gt; 10</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2011</verification_date>
	<keyword>antidepressant action</keyword>
	<keyword>clinical psychopharmacology</keyword>
</DOC>